Clinical Trial Update: Blood Pressure Reduction Induced by CPAP in Sleep Apnea Patients at High Cardiovascular Risk : OPTISAS 2 Study [Phase 4]

View source ↗

Summary

Phase 4 OPTISAS 2 trial reports that CPAP therapy reduces blood pressure in sleep apnea patients at high cardiovascular risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Sleep Apnea

Snippet

Sponsor: Fédération Française de Pneumologie | Conditions: Sleep Apnea Syndromes, High Cardiovascular Risk | Phase 4 | Status: UNKNOWN